You just read:

PROCLAIM Patient Registry Data Demonstrate Survival Benefit of First-line Proleukin® Therapy in Patients with Metastatic Renal Cell Carcinoma

News provided by

Prometheus Laboratories, Inc.

May 28, 2015, 08:00 ET